Sharma Mani: insider trades.
Sharma Mani reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 1 open-market purchase ($3K) and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 1
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Sharma Mani
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Astrazeneca Plc (AZN) | Officer · See Remarks | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Astrazeneca Plc | A | 1 | $162.6 | 19,289 | Form 4 |
| 2026-08-08 | Astrazeneca Plc | P | 20 | $160.57 | 19,288 | Form 4 |
| 2026-08-06 | Astrazeneca Plc | A | 2 | $163.34 | 19,267 | Form 4 |
| 2026-07-06 | Astrazeneca Plc | A | 2 | $190.43 | 19,265 | Form 4 |
Questions
What stock did Sharma Mani buy or sell?
Sharma Mani reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 1 open-market purchase ($3K) and 0 sales, across 1 company.
Is Sharma Mani the same person as other filers with this name?
This page covers SEC CIK 2122411 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/sharma-mani-2122411.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.